[go: up one dir, main page]

CL2009001149A1 - Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos. - Google Patents

Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos.

Info

Publication number
CL2009001149A1
CL2009001149A1 CL2009001149A CL2009001149A CL2009001149A1 CL 2009001149 A1 CL2009001149 A1 CL 2009001149A1 CL 2009001149 A CL2009001149 A CL 2009001149A CL 2009001149 A CL2009001149 A CL 2009001149A CL 2009001149 A1 CL2009001149 A1 CL 2009001149A1
Authority
CL
Chile
Prior art keywords
diols
pyrimidine
thieno
disubstituted
dihydro
Prior art date
Application number
CL2009001149A
Other languages
English (en)
Inventor
Dhileepkumar Krishnamurthy
Thomas G Tampone
Frutos Rogelio Peres
Jason Alan Mulder
Chris Hugh Senanayake
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41319263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009001149(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2009001149A1 publication Critical patent/CL2009001149A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Procedimiento de preparación de compuestos derivados de dihidrotieno[3,2-d]pirimidina-dioles sustituidos; compuestos intermediarios; útiles como antihipertensivos, hipoglicemicos, entre otras enfermedades.
CL2009001149A 2008-05-13 2009-05-12 Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos. CL2009001149A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5281608P 2008-05-13 2008-05-13

Publications (1)

Publication Number Publication Date
CL2009001149A1 true CL2009001149A1 (es) 2010-07-23

Family

ID=41319263

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001149A CL2009001149A1 (es) 2008-05-13 2009-05-12 Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos.

Country Status (31)

Country Link
US (1) US8471010B2 (es)
EP (1) EP2315755B1 (es)
JP (1) JP5281153B2 (es)
KR (1) KR20110021764A (es)
CN (1) CN102026984B (es)
AR (1) AR071720A1 (es)
AU (1) AU2009246686B2 (es)
BR (1) BRPI0912546A2 (es)
CA (1) CA2722970A1 (es)
CL (1) CL2009001149A1 (es)
CO (1) CO6260135A2 (es)
CY (1) CY1113577T1 (es)
DK (1) DK2315755T3 (es)
EA (1) EA019735B1 (es)
EC (1) ECSP10010571A (es)
ES (1) ES2392920T3 (es)
HR (1) HRP20120860T1 (es)
IL (1) IL208382A0 (es)
MA (1) MA32312B1 (es)
ME (1) ME01465B (es)
MX (1) MX2010011025A (es)
MY (1) MY152292A (es)
NZ (1) NZ588484A (es)
PL (1) PL2315755T3 (es)
PT (1) PT2315755E (es)
RS (1) RS52476B (es)
SI (1) SI2315755T1 (es)
TW (1) TWI421254B (es)
UA (1) UA99964C2 (es)
WO (1) WO2009140127A2 (es)
ZA (1) ZA201006891B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
US9173884B2 (en) 2011-11-30 2015-11-03 Trustees Of Boston College Inhibitors of phosphodiesterase 11 (PDE11)
WO2025131986A1 (en) 2023-12-19 2025-06-26 Boehringer Ingelheim International Gmbh Novel synthetic steps for the manufacturing method of the pde4b-inhibitor 1-({(5r)-2-[4-(5-chloropyrimidine-2-yl)piperidine-1-yl]-5-oxido-6,7-dihydrothieno[3,2-d]pyrimidine-4-yl}amino)cyclobutyl]methanol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470336A1 (de) * 1962-07-04 1969-03-20 Thomae Gmbh Dr K Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
FR2029250A5 (es) * 1969-01-21 1970-10-16 Roussel Uclaf
TW200410975A (en) * 2002-09-26 2004-07-01 Nihon Nohyaku Co Ltd New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it
EP1874781B9 (de) * 2006-04-19 2010-09-08 Boehringer Ingelheim International GmbH Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
US7851468B2 (en) * 2006-05-15 2010-12-14 Cephalon, Inc. Substituted pyrazolo[3,4-d]pyrimidines

Also Published As

Publication number Publication date
CY1113577T1 (el) 2016-06-22
IL208382A0 (en) 2010-12-30
WO2009140127A3 (en) 2010-01-28
ZA201006891B (en) 2011-06-29
PT2315755E (pt) 2012-10-03
JP5281153B2 (ja) 2013-09-04
AU2009246686B2 (en) 2014-02-13
TWI421254B (zh) 2014-01-01
EA201001775A1 (ru) 2011-06-30
UA99964C2 (en) 2012-10-25
AU2009246686A1 (en) 2009-11-19
BRPI0912546A2 (pt) 2016-10-18
KR20110021764A (ko) 2011-03-04
JP2011520886A (ja) 2011-07-21
HRP20120860T1 (hr) 2012-11-30
MY152292A (en) 2014-09-15
ME01465B (me) 2014-04-20
EA019735B1 (ru) 2014-05-30
ECSP10010571A (es) 2010-11-30
DK2315755T3 (da) 2012-10-15
AR071720A1 (es) 2010-07-07
SI2315755T1 (sl) 2012-10-30
MX2010011025A (es) 2010-11-05
HK1151524A1 (en) 2012-02-03
CO6260135A2 (es) 2011-03-22
WO2009140127A2 (en) 2009-11-19
MA32312B1 (fr) 2011-05-02
US20110130563A1 (en) 2011-06-02
ES2392920T3 (es) 2012-12-17
CN102026984B (zh) 2013-12-25
EP2315755A2 (en) 2011-05-04
EP2315755B1 (en) 2012-08-08
RS52476B (sr) 2013-02-28
US8471010B2 (en) 2013-06-25
NZ588484A (en) 2012-06-29
TW201006841A (en) 2010-02-16
CA2722970A1 (en) 2009-11-19
CN102026984A (zh) 2011-04-20
PL2315755T3 (pl) 2013-01-31

Similar Documents

Publication Publication Date Title
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
CR20110620A (es) Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus
TN2009000215A1 (en) Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
MX2012011779A (es) Pirimidinas modificadas en la posicion 5 y su uso.
GEP20146072B (en) New compounds
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
DOP2011000171A (es) Compuestos organico
MX370814B (es) Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
BRPI0923786C1 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos
CL2008000670A1 (es) Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras.
PH12013500031A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
WO2011080568A8 (en) Novel pyrimidine compounds as mtor and pi3k inhibitors
CL2012003604A1 (es) Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros.
PH12014500813A1 (en) Novel [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor
WO2008083950A8 (de) Spirocyclische tetronsäure-derivative
CY1112877T1 (el) Μεταλλαγματα αυξητικου παραγoντα υψηλης δραστικοτητας
BRPI0614397A2 (pt) compostos de pirimidina como moduladores de receptor de serotonina
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
UA106724C2 (uk) Спосіб отримання заміщених піримідинових похідних
CL2009001149A1 (es) Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos.
TNSN07462A1 (en) Ampa receptor potentiators
TN2015000128A1 (en) Solid form of dihydro-pyrido-oxazine derivative
EA200801404A1 (ru) Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она
NZ593021A (en) Method of preparing deoxyribofuranose compounds